About this document

OnabotulinumtoxinA for Pediatric Spasticity by zzeiger1234 is a document available to read on EtoBox.

This phase III trial evaluated the efficacy and safety of onabotulinumtoxinA combined with occupational therapy for treating pediatric upper limb spasticity. Results showed significant reductions in spasticity as measured by the Modified Ashworth Scale, with both doses (3 U/kg and 6 U/kg) being effective and safe. The study concluded that onabotulinumtoxinA is a beneficial treatment option for children with spasticity related to cerebral palsy.

Author

zzeiger1234

Language

EN